Manfred Kaufmann

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

Gϋnter von Minckwitz, Michael Untch, Jens‐Uwe Blohmer et al. · Journal of Clinical Oncology · 2012 · 2.6K citations

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial

Ian Smith, Marion Procter, Richard D. Gelber et al. · The Lancet · 2007 · 1.5K citations

Breast Oncology, Medicine, Adjuvant Chemotherapy +6

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

R. Jakesz, W. Jonat, Michael Gnant et al. · The Lancet · 2005 · 871 citations

Breast Oncology, Medicine, Pharmacology +10

Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment

Ingo Diel, Erich‐Franz Solomayer, Serban Dan Costa et al. · New England Journal of Medicine · 1998 · 808 citations · Full text

Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update

Manfred Kaufmann, Gabriel N. Hortobágyi, Aron Goldhirsch et al. · Journal of Clinical Oncology · 2006 · 718 citations · Full text

Surgical Oncology, Breast Oncology, Medicine +13